Get the Stockscreener App
232.43
1.53%
-3.62
Pre-market:
232.43
Iqvia Holdings Inc stock is traded at $232.43, with a volume of 1.22M.
It is down -1.53% in the last 24 hours and up +12.85% over the past month.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
See More
Previous Close:
$236.05
Open:
$236
24h Volume:
1.22M
Relative Volume:
0.75
Market Cap:
$38.79B
Revenue:
$16.63B
Net Income/Loss:
$1.39B
P/E Ratio:
28.81
EPS:
8.0674
Net Cash Flow:
$2.12B
1W Performance:
-2.25%
1M Performance:
+12.85%
6M Performance:
+23.97%
1Y Performance:
+30.95%
1-Day Range:
$228.76
$236.80
1-Week Range:
$227.15
$238.49
52-Week Range:
$154.50
$251.36
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
232.43 | 35.59B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
580.02 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
199.98 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
590.00 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
141.34 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
399.70 | 36.45B | 3.77B | 449.25M | 240.68M | 7.8556 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-26 | Upgrade | TD Cowen | Hold → Buy |
| Mar-06-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
[IQV Q2 2026 Earnings Call] IQVIA Crushes Q2 with $4.37B Revenue, Record Bookings, and Guidance Raise - finance.biggo.com
IQVIA Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised - TradingView
IQV: Q2 revenue and EPS exceeded guidance, driven by strong AI-enabled growth and robust demand - TradingView
IQVIA Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
IQVIA Holdings Releases Q2 2026 Financial Results - AlphaStreet
IQVIA surges on Q2 beat and guidance hike - Seeking Alpha
IQVIA Holdings Inc. Raises Earnings Guidance for the Year 2026 - marketscreener.com
IQVIA Hldgs Q2 Results: Adjusted EPS beats estimates by 3.96% - scanx.trade
IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
IQV Looks 14.9% Undervalued on GF Value™ - GuruFocus
How Did IQVIA Holdings Inc (IQV) Perform in Q2 2026? EPS at $3.1 - GuruFocus
Earnings Flash (IQV) IQVIA Holdings Inc. Reports Q2 Revenue $4.37B, vs. FactSet Est of $4.30B - marketscreener.com
Earnings Flash (IQV) IQVIA Holdings Inc. Posts Q2 Adjusted EPS $3.15 per Share, vs. FactSet Est of $3.03 - marketscreener.com
IQV: Revenue and earnings grew strongly in Q2 2026, prompting raised full-year guidance - TradingView
IQVIA Holdings earnings beat by $0.11, revenue topped estimates - Investing.com Australia
IQVIA: Q2 Earnings Snapshot - KTVB
IQVIA reports Q2 2026 revenue $4,368M, adjusted EPS $3.15 and raises full-year guidance - TradingView
IQVIA Holdings (NYSE: IQV) grows Q2 revenue to $4.37B and raises 2026 outlook - Stock Titan
IQVIA Reports Second-Quarter 2026 Results - Business Wire
IQV|IQVIA Holdings Inc|Price:213.460|Chg%:+5.410 - TradingKey
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA earnings up next: Can AI expand CRO demand or squeeze margins? - Investing.com UK
IQV Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Innovation with an 11.51% Upside Potential - DirectorsTalk Interviews
IQVIA Holdings stock trades steady as data-driven growth supports valuation - Ad-hoc-news.de
Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow - Yahoo Finance
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
IQVIA Holdings stock trades near record territory as data-driven growth supports valuation - Ad-hoc-news.de
IQVIA Holdings Inc (IQV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IQVIA Holdings Inc (IQV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IQVIA Holdings Inc (IQV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IQVIA Holdings Inc (IQV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IQVIA Holdings Inc (IQV) Cash Flow - TradingKey
IQVIA Holdings Inc (IQV) Balance Sheet - TradingKey
Diversified Trust Co's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Gears Up to Report Q2 Earnings: What's in the Offing? - TradingView
IQV|IQVIA Holdings Inc|Price:209.370|Chg%:+2.050 - TradingKey
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout | AI
IQVIA Holdings (IQV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
IQVIA stock trades steadily as data and technology demand supports growth - Ad-hoc-news.de
IQVIA Holdings Inc (IQV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IQV: IQVIA Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IQVIA Holdings Inc (IQV) Shares Surge 4.4% -- What GF Score of 8 - GuruFocus
Why IQVIA (IQV) Stock Is Up Today - Quiver Quantitative
IQVIA BDR program executes 4-for-1 stock split in Brazil on Aug. 26 - Bitget
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IQVIA Holdings (IQV) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
IQVIA Holdings stock holds its ground as investors await fresh data - Ad-hoc-news.de
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IQVIA Holdings stock trades steady as data-driven growth supports recent earnings - Ad-hoc-news.de
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Iqvia Holdings Inc Stock (IQV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Patel Bhavik | See Remarks |
Jul 31 '26 |
Sale |
235.27 |
1,855 |
436,426 |
1,348 |
0.08%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):